Participants with ulcerative colitis.
Participants with Crohn’s disease.
Participants that are obese.
Participants with colon polyps.
Participants with Eosinophilic esophagitis
Participants with Gastroesophageal Reflux Disease (GERD).
Participants with gastritis.
Participants with gastric ulcers.
Participants with duodenal ulcers.
Participants with intestinal metaplasia (risk factor for esophageal cancer).
Participants with gastric cancer.
Participants with Lymphocytic/Microscopic Colitis.
Participants with Celiac Sprue.
Participants with IBS.
Participants with SIBO.
Participants with NAFLD.
Participants with Gallstone disease.
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
